International Desk

FDA failed to follow own guidance in approving Biogen's Alzheimer's drug, says report

WASHINGTON: The FDA failed to follow its own guidance and internal practices during the approval process for Biogen's (BIIB.O) Alzheimer's drug Aduhelm, which was "rife with irregularities," accord...

Read More